Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Cerebral small vessel disease (cSVD) has a crucial role in lacunar stroke and brain hemorrhages and is a leading cause of cognitive decline and functional loss in elderly patients. Based on underlying pathophysiology, cSVD can be subdivided into amyloidal and non-amyloidal subtypes. Genetic factors of cSVD play a pivotal role in terms of unraveling molecular mechanism. An important pathophysiological mechanism of cSVD is blood-brain barrier leakage and endothelium dysfunction which gives a clue in identification of the disease through circulating biological markers. Detection of cSVD is routinely carried out by key neuroimaging markers including white matter hyperintensities, lacunes, small subcortical infarcts, perivascular spaces, cerebral microbleeds, and brain atrophy. Application of neural networking, machine learning and deep learning in image processing have increased significantly for correct severity of cSVD. A linkage between cSVD and other neurological disorder, such as Alzheimer’s and Parkinson’s disease and non-cerebral disease, has also been investigated recently. This review draws a broad picture of cSVD, aiming to inculcate new insights into its pathogenesis and biomarkers. It also focuses on the role of deep machine strategies and other dimensions of cSVD by linking it with several cerebral and non-cerebral diseases as well as recent advances in the field to achieve sensitive detection, effective prevention and disease management.
Abstract
Cerebral small vessel disease (cSVD) has a crucial role in lacunar stroke and brain hemorrhages and is a leading cause of cognitive decline and functional loss in elderly patients. Based on underlying pathophysiology, cSVD can be subdivided into amyloidal and non-amyloidal subtypes. Genetic factors of cSVD play a pivotal role in terms of unraveling molecular mechanism. An important pathophysiological mechanism of cSVD is blood-brain barrier leakage and endothelium dysfunction which gives a clue in identification of the disease through circulating biological markers. Detection of cSVD is routinely carried out by key neuroimaging markers including white matter hyperintensities, lacunes, small subcortical infarcts, perivascular spaces, cerebral microbleeds, and brain atrophy. Application of neural networking, machine learning and deep learning in image processing have increased significantly for correct severity of cSVD. A linkage between cSVD and other neurological disorder, such as Alzheimer’s and Parkinson’s disease and non-cerebral disease, has also been investigated recently. This review draws a broad picture of cSVD, aiming to inculcate new insights into its pathogenesis and biomarkers. It also focuses on the role of deep machine strategies and other dimensions of cSVD by linking it with several cerebral and non-cerebral diseases as well as recent advances in the field to achieve sensitive detection, effective prevention and disease management.
참고문헌 (161)
- Feigin VL, "Global burden of stroke", Circ Res, 120, pp.439~448 (2017)
- "Stroke facts" (2017)[URL]
- Gomes J, "Handbook of Clinical Nutrition and Stroke", pp.15~32 (2013), Springer
- Pantoni L, "Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges", Lancet Neurol, 9, pp.689~701 (2010)
- Uiterwijk R, "Total cerebral small vessel disease MRI score is associated with cognitive decline in executive function in patients with hypertension", Front Aging Neurosci, 8, pp.301~ (2016)
- Taylor WD, "The vascular depression hypothesis: mechanisms linking vascular disease with depression", Mol Psychiatry, 18, pp.963~974 (2013)
- Pinter D, "Impact of small vessel disease in the brain on gait and balance", Sci Rep, 7, pp.41637~ (2017)
- Farrall AJ, "Blood-brain barrier: ageing and microvascular disease: systematic review and meta-analysis", Neurobiol Aging, 30, pp.337~352 (2009)
- Fisher CM, "Lacunar strokes and infarcts: a review", Neurology, 32, pp.871~876 (1982)
- Charidimou A, "The concept of sporadic cerebral small vessel disease: a road map on key definitions and current concepts", Int J Stroke, 11, pp.6~18 (2016)
- Alessandro Biffi, "Cerebral Amyloid Angiopathy: A Systematic Review", Journal of Clinical Neurology, 7(1), pp.1~9 (2011), 대한신경과학회
- Charidimou A, "Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum", J Neurol Neurosurg Psychiatry, 83, pp.124~137 (2012)
- Vinters HV, "Cerebral amyloid angiopathy. A critical review", Stroke, 18, pp.311~324 (1987)
- Love S, "Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy", Front Biosci (Landmark Ed), 14, pp.4778~4792 (2009)
- Charidimou A, "Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?", Lancet Neurol, 13, pp.538~540 (2014)
- Kirshner HS, "The inflammatory form of cerebral amyloid angiopathy or "cerebral amyloid angiopathy-related inflammation" (CAARI)", Curr Neurol Neurosci Rep, 15, pp.54~ (2015)
- Raposo N, "Florbetapir imaging in cerebral amyloid angiopathyrelated hemorrhages", Neurology, 89, pp.697~704 (2017)
- Thal DR, "Two types of sporadic cerebral amyloid angiopathy", J Neuropathol Exp Neurol, 61, pp.282~293 (2002)
- van Opstal AM, "Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study", Lancet Neurol, 16, pp.115~122 (2017)
- Fotiadis P, "Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study", Lancet Neurol, 15, pp.811~819 (2016)
- Lammie GA, "Hypertensive cerebral small vessel disease and stroke", Brain Pathol, 12, pp.358~370 (2002)
- Rosenblum WI, "Cerebral hemorrhage produced by ruptured dissecting aneurysm in miliary aneurysm", Ann Neurol, 54, pp.376~378 (2003)
- Louis R Caplan, "Lacunar Infarction and Small Vessel Disease: Pathology and Pathophysiology", 대한뇌졸중영문학회지, 17(1), pp.2~6 (2015), 대한뇌졸중학회
- Szpak GM, "Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies", Folia Neuropathol, 45, pp.192~204 (2007)
- Fazekas F, "Pathologic correlates of incidental MRI white matter signal hyperintensities", Neurology, 43, pp.1683~1689 (1993)
- van Swieten JC, "Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces", Brain, 114, pp.761~774 (1991)
- Fisher CM, "The arterial lesions underlying lacunes", Acta Neuropathol, 12, pp.1~15 (1968)
- Muller K, "New insight Into the pathogenesis of cerebral small-vessel diseases", Stroke, 48, pp.520~527 (2017)
- Jay Chol Choi, "Genetics of Cerebral Small Vessel Disease", 대한뇌졸중영문학회지, 17(1), pp.7~16 (2015), 대한뇌졸중학회
- Joutel A, "Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia", Nature, 383, pp.707~710 (1996)
- Tikka S, "CADASIL and CARASIL", Brain Pathol, 24, pp.525~544 (2014)
- Iejima D, "HTRA1 (high temperature requirement A serine peptidase 1) gene is transcriptionally regulated by insertion", deletion nucleotides located at the 3' end of the ARMS2 (agerelated maculopathy susceptibility 2) gene in patients with age-related macular degeneration, 2015, pp.290, 2784~2797
- Gould DB, "Role of COL4A1 in small-vessel disease and hemorrhagic stroke", N Engl J Med, 354, pp.1489~1496 (2006)
- Kolar GR, "Neuropathology and genetics of cerebroretinal vasculopathies", Brain Pathol, 24, pp.510~518 (2014)
- Hsu TR, "Fabry disease: review and experience during newborn screening", Trends Cardiovasc Med, 28, pp.274~281 (2018)
- Wardlaw JM, "Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging", Lancet Neurol, 12, pp.483~497 (2013)
- Wardlaw JM, "Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?", Stroke, 34, pp.806~812 (2003)
- Poggesi A, "Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review", J Cereb Blood Flow Metab, 36, pp.72~94 (2016)
- Wolburg H, "Tight junctions of the blood-brain barrier: development, composition and regulation", Vascul Pharmacol, 38, pp.323~337 (2002)
- Hawkins BT, "The blood-brain barrier", neurovascular unit in health and disease, 2005, pp.57, 173~185
- Zhang CE, "Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease", Neurology, 88, pp.426~432 (2017)
- Wardlaw JM, "Lacunar stroke is associated with diffuse blood-brain barrier dysfunction", Ann Neurol, 65, pp.194~202 (2009)
- Topakian R, "Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis", J Neurol Neurosurg Psychiatry, 81, pp.192~197 (2010)
- Huisa BN, "Long-term blood-brain barrier permeability changes in Binswanger disease", Stroke, 46, pp.2413~2418 (2015)
- Wardlaw JM, "Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study", Alzheimers Dement, 13, pp.634~643 (2017)
- Ihara M, "Emerging evidence for pathogenesis of sporadic cerebral small vessel disease", Stroke, 47, pp.554~560 (2016)
- Rajani RM, "Endothelial cell-oligodendrocyte interactions in small vessel disease and aging", Clin Sci (Lond), 131, pp.369~379 (2017)
- Armulik A, "Endothelial", pericyte interactions, 2005, pp.97, 512~523
- Deplanque D, "Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a casecontrol study", Int J Stroke, 8, pp.413~421 (2013)
- Young VG, "Neuropathologic correlates of white matter hyperintensities", Neurology, 71, pp.804~811 (2008)
- Markus HS, "Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study", Stroke, 36, pp.1410~1414 (2005)
- van Dijk EJ, "C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study", Circulation, 112, pp.900~905 (2005)
- Fornage M, "Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study", Stroke, 39, pp.1952~1959 (2008)
- Satizabal CL, "Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study", Neurology, 78, pp.720~727 (2012)
- Notsu Y, "Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage", Am J Hypertens, 22, pp.257~262 (2009)
- Pikula A, "Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study", Stroke, 40, pp.2959~2964 (2009)
- Kim Y, "Circulating matrix metalloproteinase-9 level is associated with cerebral white matter hyperintensities in non-stroke individuals", Eur Neurol, 72, pp.234~240 (2014)
- Rouhl RP, "Vascular inflammation in cerebral small vessel disease", Neurobiol Aging, 33, pp.1800~1806 (2012)
- Rufa A, "Plasma levels of asymmetric dimethylarginine in cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy", Cerebrovasc Dis, 26, pp.636~640 (2008)
- Pescini F, "Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", Stroke, 41, pp.218~223 (2010)
- Vermeer SE, "Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study", Ann Neurol, 51, pp.285~289 (2002)
- Kloppenborg RP, "Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMARTMR study", Atherosclerosis, 216, pp.461~466 (2011)
- Sachdev P, "Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men", Arch Neurol, 61, pp.1369~1376 (2004)
- Aono Y, "Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: the Ohasama study", Arterioscler Thromb Vasc Biol, 27, pp.963~968 (2007)
- Bridges LR, "Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people", J Neuropathol Exp Neurol, 73, pp.1026~1033 (2014)
- Knottnerus IL, "Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients", Neurology, 78, pp.493~498 (2012)
- Kario K, "Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects", J Am Coll Cardiol, 37, pp.871~877 (2001)
- Simpson JE, "White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses", Neuropathol Appl Neurobiol, 33, pp.410~419 (2007)
- Skoog I, "A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia", Neurology, 50, pp.966~971 (1998)
- Pantoni L, "Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function", J Neurol Sci, 115, pp.125~131 (1993)
- Vogels SC, "The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review", Maturitas, 71, pp.331~336 (2012)
- Stehouwer CD, "Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms", J Am Soc Nephrol, 17, pp.2106~2111 (2006)
- Georgakis MK, "Albuminuria and cerebral small vessel disease: a systematic review and meta-analysis", J Am Geriatr Soc, 66, pp.509~517 (2018)
- Gattringer T, "Serum neurofilament light is sensitive to active cerebral small vessel disease", Neurology, 89, pp.2108~2114 (2017)
- Rannikmae K, "Common variation in COL4A1", COL4A2 is associated with sporadic cerebral small vessel disease, 2015, pp.84, 918~926
- Rajashekhar G, "Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation", J Vasc Res, 43, pp.193~204 (2006)
- Laurent S, "Large and small artery crosstalk and recent morbidity-mortality trials in hypertension", Hypertension, 54, pp.388~392 (2009)
- Bailey EL, "Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review", Int J Stroke, 6, pp.434~444 (2011)
- Khan U, "Risk factor profile of cerebral small vessel disease and its subtypes", J Neurol Neurosurg Psychiatry, 78, pp.702~706 (2007)
- Boulouis G, "Intracranial atherosclerosis and cerebral small vessel disease in intracerebral hemorrhage patients", J Neurol Sci, 369, pp.324~329 (2016)
- Brisset M, "Large-vessel correlates of cerebral small-vessel disease", Neurology, 80, pp.662~669 (2013)
- Aribisala BS, "Blood pressure, internal carotid artery flow parameters, and age-related white matter hyperintensities", Hypertension, 63, pp.1011~1018 (2014)
- Hattori Y, "Silent information regulator 2 homolog 1 counters cerebral hypoperfusion injury by deacetylating endothelial nitric oxide synthase", Stroke, 45, pp.3403~3411 (2014)
- Kitamura A, "Gradual cerebral hypoperfusion in spontaneously hypertensive rats induces slowly evolving white matter abnormalities and impairs working memory", J Cereb Blood Flow Metab, 36, pp.1592~1602 (2016)
- Poels MM, "Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study", Stroke, 43, pp.2637~2642 (2012)
- Huang X, "Evaluation of carotid artery elasticity changes in patients with cerebral small vessel disease", Int J Clin Exp Med, 8, pp.18825~18830 (2015)
- Vermeer SE, "Silent brain infarcts: a systematic review", Lancet Neurol, 6, pp.611~619 (2007)
- Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
- Bo Norrving, "Evolving Concept of Small Vessel Disease through Advanced Brain Imaging", 대한뇌졸중영문학회지, 17(2), pp.94~100 (2015), 대한뇌졸중학회
- Staals J, "Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden", Neurology, 83, pp.1228~1234 (2014)
- Lyoubi-Idrissi AL, "Diffusion magnetic resonance imaging in cerebral small vessel disease", Rev Neurol (Paris), 173, pp.201~210 (2017)
- Farid K, "Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: a systematic critical update", Neuroimage Clin, 15, pp.247~263 (2017)
- Klarenbeek P, "Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease", Stroke, 44, pp.2995~2999 (2013)
- Rawat W, "Deep convolutional neural networks for image classification: a comprehensive review", Neural Comput, 29, pp.2352~2449 (2017)
- Litjens G, "A survey on deep learning in medical image analysis", Med Image Anal, 42, pp.60~88 (2017)
- Shi Z, "Survey on neural networks used for medical image processing", Int J Comput Sci, 3, pp.86~100 (2009)
- Shen D, "Machine learning in medical imaging", Comput Med Imaging Graph, 41, pp.1~2 (2015)
- Araki T, "Stroke risk stratification and its validation using ultrasonic echolucent carotid wall plaque morphology: a machine learning paradigm", Comput Biol Med, 80, pp.77~96 (2017)
- Saba L, "Plaque tissue morphology-based stroke risk stratification using carotid ultrasound: a polling-based PCA learning paradigm", J Med Syst, 41, pp.98~ (2017)
- Lambert C, "Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease", Neuroimage Clin, 9, pp.194~205 (2015)
- Ciulli S, "Prediction of impaired performance in trail making test in MCI patients with small vessel disease using DTI data", IEEE J Biomed Health Inform, 20, pp.1026~1033 (2016)
- Gonzalez-Castro V, "Reliability of an automatic classifier for brain enlarged perivascular spaces burden and comparison with human performance", Clin Sci (Lond), 131, pp.1465~1481 (2017)
- Shrivastava VK, "A novel and robust Bayesian approach for segmentation of psoriasis lesions and its risk stratification", Comput Methods Programs Biomed, 150, pp.9~22 (2017)
- Kuppili V, "Extreme learning machine framework for risk stratification of fatty liver disease using ultrasound tissue characterization", J Med Syst, 41, pp.152~ (2017)
- Than JCM, "Lung disease stratification using amalgamation of Riesz and Gabor transforms in machine learning framework", Comput Biol Med, 89, pp.197~211 (2017)
- Takeuchi M, "Novel risk assessment tool for immunoglobulin resistance in Kawasaki disease: application using a random forest classifier", Pediatr Infect Dis J, 36, pp.821~826 (2017)
- Tay D, "A novel neural-inspired learning algorithm with application to clinical risk prediction", J Biomed Inform, 54, pp.305~314 (2015)
- Papageorgiou EI, "A risk management model for familial breast cancer: a new application using Fuzzy Cognitive Map method", Comput Methods Programs Biomed, 122, pp.123~135 (2015)
- Khalifa A, "Adapting existing natural language processing resources for cardiovascular risk factors identification in clinical notes", J Biomed Inform, 58(Suppl), pp.S128~S132 (2015)
- Modinos G, "Multivariate pattern classification reveals differential brain activation during emotional processing in individuals with psychosis proneness", Neuroimage, 59, pp.3033~3041 (2012)
- Lin HC, "An application of artificial immune recognition system for prediction of diabetes following gestational diabetes", J Med Syst, 35, pp.283~289 (2011)
- Kurz DJ, "Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model", Heart, 95, pp.662~668 (2009)
- LeCun Y, "Deep learning", Nature, 521, pp.436~444 (2015)
- Sahiner B, "Classification of mass and normal breast tissue: a convolution neural network classifier with spatial domain and texture images", IEEE Trans Med Imaging, 15, pp.598~610 (1996)
- Ghafoorian M, "Deep multi-scale location-aware 3D convolutional neural networks for automated detection of lacunes of presumed vascular origin", Neuroimage Clin, 14, pp.391~399 (2017)
- Ghafoorian M, "Location sensitive deep convolutional neural networks for segmentation of white matter hyperintensities", Sci Rep, 7, pp.5110~ (2017)
- Cai Z, "Cerebral small vessel disease and Alzheimer's disease", Clin Interv Aging, 10, pp.1695~1704 (2015)
- Kandimalla RJ, "Apo-E4 allele in conjunction with Abeta42 and tau in CSF: biomarker for Alzheimer's disease", Curr Alzheimer Res, 8, pp.187~196 (2011)
- Gurol ME, "Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy", Neurology, 66, pp.23~29 (2006)
- Nakata-Kudo Y, "Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease", Dement Geriatr Cogn Disord, 22, pp.8~14 (2006)
- Goos JD, "Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease", Neurobiol Aging, 33, pp.1011.e1~1011.e9 (2012)
- Brundel M, "High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease", J Alzheimers Dis, 31, pp.259~263 (2012)
- Guo H, "Evaluation of common structural brain changes in aging and Alzheimer disease with the use of an MRI-based brain atrophy and lesion index: a comparison between T1WI and T2WI at 1.5T and 3T", AJNR Am J Neuroradiol, 35, pp.504~512 (2014)
- Aribisala BS, "Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936", Eur Radiol, 23, pp.1084~1092 (2013)
- Kovacic JC, "Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease", Mt Sinai J Med, 79, pp.664~673 (2012)
- Kester MI, "Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers", JAMA Neurol, 71, pp.855~862 (2014)
- Nestor SM, "Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease", Alzheimers Dement, 13, pp.749~760 (2017)
- Tai SY, "Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study", BMC Neurol, 17, pp.40~ (2017)
- Song IU, "Parkinson's disease might increase the risk of cerebral ischemic lesions", Int J Med Sci, 14, pp.319~322 (2017)
- de Laat KF, "Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs", Stroke, 43, pp.2574~2579 (2012)
- van der Holst HM, "Cerebral small vessel disease and incident parkinsonism: the RUN DMC study", Neurology, 85, pp.1569~1577 (2015)
- Hatate J, "Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors", Parkinsonism Relat Disord, 26, pp.29~34 (2016)
- Pavlovic AM, "Transcranial parenchymal sonographic findings in patients with cerebral small vessel disease: a preliminary study", J Ultrasound Med, 34, pp.1853~1859 (2015)
- Pantoni L, "The relation between whitematter lesions and cognition", Curr Opin Neurol, 20, pp.390~397 (2007)
- Carey CL, "Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly", Stroke, 39, pp.397~402 (2008)
- Pavlovic AM, "Baseline predictors of cognitive decline in patients with cerebral small vessel disease", J Alzheimers Dis, 42(Suppl 3), pp.S37~S43 (2014)
- Xu X, "Association of magnetic resonance imaging markers of cerebrovascular disease burden and cognition", Stroke, 46, pp.2808~2814 (2015)
- Biesbroek JM, "Lesion location and cognitive impact of cerebral small vessel disease", Clin Sci (Lond), 131, pp.715~728 (2017)
- Gorelick PB, "Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association", american stroke association, 2011, pp.42, 2672~2713
- Miwa K, "Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors", Neurology, 83, pp.646~653 (2014)
- Chen A, "Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and poststroke dementia", Brain, 139, pp.242~258 (2016)
- Miwa K, "Increased total homocysteine levels predict the risk of incident dementia independent of cerebral smallvessel diseases and vascular risk factors", J Alzheimers Dis, 49, pp.503~513 (2016)
- van Sloten TT, "Cerebral small vessel disease and association with higher incidence of depressive symptoms in a general elderly population: the AGES-Reykjavik study", Am J Psychiatry, 172, pp.570~578 (2015)
- Pasi M, "Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease", Neurology, 88, pp.2162~2168 (2017)
- Pasi M, "White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany study", Int J Geriatr Psychiatry, 31, pp.611~618 (2016)
- Maxwell H, "Prevalence and subtypes of radiological cerebrovascular disease in late-onset isolated seizures and epilepsy", Clin Neurol Neurosurg, 115, pp.591~596 (2013)
- De Reuck J, "Seizures and epilepsy in patients with lacunar strokes", J Neurol Sci, 263, pp.75~78 (2007)
- Russo E, "Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats", Brain Res Bull, 130, pp.245~250 (2017)
- van der Holst HM, "Factors associated with 8-year mortality in older patients with cerebral small vessel disease: the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) study", JAMA Neurol, 73, pp.402~409 (2016)
- Lieb JM, "Normal pressure hydrocephalus", Radiologe, 55, pp.389~396 (2015)
- Kuriyama N, "Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan: epidemiological and clinical characteristics", Brain Behav, 7, pp.e00635~ (2017)
- imaging are associated with balance and gait speed, "J Neurol Neurosurg Psychiatry", 2003, 94~98
- de Laat KF, "Microbleeds are independently related to gait disturbances in elderly individuals with cerebral small vessel disease", Stroke, 42, pp.494~497 (2011)
- Zhang X, "Subclinical hypothyroidism and risk of cerebral small vessel disease: a hospital-based observational study", Clin Endocrinol (Oxf), 87, pp.581~586 (2017)
- Morgello S, "HCV, but not HIV, is a risk factor for cerebral small vessel disease", Neurol Neuroimmunol Neuroinflamm, 1, pp.e27~ (2014)
- Chow FC, "Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system", J Acquir Immune Defic Syndr, 60, pp.351~358 (2012)
- Rasmussen LD, "Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study", AIDS, 25, pp.1637~1646 (2011)
- Worm SW, "Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study", J Infect Dis, 201, pp.318~330 (2010)
- Soontornniyomkij V, "HIV protease inhibitor exposure predicts cerebral small vessel disease", AIDS, 28, pp.1297~1306 (2014)
- McMurtray A, "Smallvessel vascular disease in human immunodeficiency virus infection: the Hawaii aging with HIV cohort study", Cerebrovasc Dis, 24, pp.236~241 (2007)
- Cho KH, "Cerebral small vessel disease in branch retinal artery occlusion", Invest Ophthalmol Vis Sci, 57, pp.5818~5824 (2016)
